Groundbreaking Immunotherapy Studies in Esophageal Cancer show Significant Benefits
Findings of three studies important to Esophageal Cancer patients were presented at the 2020 ESMO (European Society of Medical Oncology) [...]
ECAN Advocates Convince Congress to Include Esophageal Cancer in a Multi-Million Dollar Research Fund
For the second year in a row, thousands of ECAN advocates made their voices heard and convinced lawmakers in the [...]
FDA Approves First Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
The U.S. Food and Drug Administration has approved Keytruda (Pembrolizumab) for treatment of advanced Esophageal Squamous Cell Carcinoma (ESCC). It [...]
Stacy Alexander Turns 50!
The community of Athens, TN huddled together inside of the old building, the wood panels muffling their whispers and [...]
Deep Dive into Esophageal Cancer Genome
A team of UK researchers dug deep into the genomic roots of more than 550 cases of Esophageal Adenocarcinoma (EAC), [...]
Make Millions Available for Esophageal Cancer Research
ECAN's Medical Research Campaign What our Campaign Will Do: The United States Congress appropriated $90 million dollars this year for a [...]
Deep Cuts to Cancer Research
Budget Plan Risks Hard-Fought Research Gains President Trump’s budget proposal for FY 2018 calls for a drastic 20% cut to [...]
Esophageal Cancer Genome
ECAN’s President and CEO Mindy Mintz Mordecai recently had the opportunity to interview Dr. Adam Bass, co-chair of the [...]
FDA Petition for Cancer Warnings
ECAN petitioned the U.S. Food and Drug Administration (FDA) for new labels on over-the-counter (OTC) heartburn medications warning of the [...]